Simon Nitinol filter cleared by the FDA:
This article was originally published in Clinica
Executive Summary
Nitinol's filter for implantation through the subclavian vein in the shoulder has been cleared by the FDA for marketing in the US. The Simon Nitinol device is a thermal shape-memory vena cava filter designed to prevent pulmonary embolisms. Nitinol says that pulmonary embolism results in approximately 125,000 to 150,000 deaths annually in the US and represented a worldwide market in 1995 worth $53 million.